STOCK TITAN

Henry Schein Inc - HSIC STOCK NEWS

Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.

Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.

The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.

In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.

Rhea-AI Summary
Henry Schein, Inc. (NASDAQ: HSIC) appoints three new members to its Executive Management Committee, including Co-CEOs of the Global Oral Reconstruction Group and the CEO of the Healthcare Specialties Group. The new appointments aim to enhance the Company's leadership team and advance its strategic plan for higher growth and margin specialty products and services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
management
-
Rhea-AI Summary
Henry Schein, Inc. expands into the high-growth extremities market with the acquisition of TriMed, Inc., a global developer of orthopedic solutions. The acquisition strengthens Henry Schein's relationships with Integrated Delivery Networks and Ambulatory Surgery Centers, providing a wider range of surgical solutions. TriMed had 2023 net sales of approximately $52 million, and the transaction is expected to be neutral to 2024 non-GAAP earnings per share for Henry Schein.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
-
Rhea-AI Summary
Viome partners with Henry Schein to offer Oral Health Pro™ With CancerDetect™, a test to detect early biomarkers of oral and throat cancers, enhancing preventive care. The collaboration aims to revolutionize oral healthcare by providing better access to innovative technology, transforming patient outcomes and empowering healthcare professionals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
none
News
Rhea-AI Summary
Henry Schein, Inc. (HSIC) announces THRIVELIVE™ 2024, a dental event in Las Vegas offering educational courses, cutting-edge technology experiences, and networking opportunities for dental professionals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. (HSIC) has been recognized as one of the World's Most Ethical Companies® for the 13th consecutive year by Ethisphere. The company's commitment to business integrity, ethics, and governance programs has been highlighted. Henry Schein is dedicated to its stakeholders and corporate citizenship, focusing on making a healthier world through various initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. (HSIC) reports solid fourth-quarter financial results, with a GAAP diluted EPS of $0.13 and non-GAAP diluted EPS of $0.66. The company introduces 2024 guidance, expecting non-GAAP diluted EPS of $5.00 to $5.16, reflecting growth of 11% to 15% compared to 2023. Total net sales for the fourth quarter were $3.0 billion, a decrease of 10.5% compared to the same period last year. The full-year 2023 net sales were $12.3 billion, a decrease of 2.4% compared to 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.38%
Tags
Rhea-AI Summary
Henry Schein Medical, a subsidiary of Henry Schein, Inc. (HSIC), is accepting nominations for the 2024 Rising Star Award to honor emerging athletic trainers in the sports medicine industry. The award recognizes individuals with one to five years of experience who show potential for career advancement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.65%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. partners with NDA and Schattner Foundation to present the S.M.I.L.E. Healthcare Pathway Program for underrepresented high school students interested in oral health. The program offers mentorship, hands-on learning, career exposure, and a capstone project to empower future leaders in dentistry. Applications for the 2024 program at Meharry Medical College School of Dentistry are now open until March 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Summary
Henry Schein, Inc. (HSIC) will showcase a range of digital equipment, technology solutions, and business services at the 2024 Chicago Dental Society Midwinter Meeting to enhance dental practices' efficiency and patient experience. Key highlights include software solutions, merchandise products, transition planning, and revenue cycle management offerings. The company aims to empower oral health professionals through innovative products and solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Henry Schein, Inc. launches Prevention is Power™ campaign to promote integrated, preventive care and reduce chronic diseases. The initiative aims to improve health literacy, enhance patient utilization of preventive care, and lower healthcare spending. The campaign addresses the need for better health outcomes in the U.S. by encouraging routine preventive healthcare practices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
none

FAQ

What is the current stock price of Henry Schein (HSIC)?

The current stock price of Henry Schein (HSIC) is $74.75 as of January 23, 2025.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately 9.3B.

What does Henry Schein Inc. do?

Henry Schein Inc. provides healthcare products and services to office-based dental, animal health, and medical practitioners, as well as other care sites.

How many team members does Henry Schein employ?

Henry Schein employs more than 18,000 team members.

What segments does Henry Schein operate in?

Henry Schein operates in two main segments: Healthcare Distribution and Technology & Value-Added Services.

How many products does Henry Schein offer?

Henry Schein offers a selection of more than 100,000 branded and private-label products, and over 150,000 additional products as special-order items.

Who are Henry Schein's primary customers?

Henry Schein's primary customers are office-based dental, animal health, and medical practitioners, dental laboratories, and institutional health care clinics.

What kind of technology solutions does Henry Schein provide?

Henry Schein provides innovative software and technology solutions to help healthcare practitioners manage their practices efficiently.

Is Henry Schein a Fortune 500 company?

Yes, Henry Schein is a Fortune 500® company.

What stock market indexes is Henry Schein a part of?

Henry Schein is a member of the S&P 500® and NASDAQ 100® indexes.

How many customers does Henry Schein serve?

Henry Schein serves over one million customers worldwide.

Does Henry Schein have any recent achievements?

Henry Schein has expanded its product range and formed strategic partnerships to enhance its service offerings in recent years.
Henry Schein Inc

Nasdaq:HSIC

HSIC Rankings

HSIC Stock Data

9.32B
123.38M
0.9%
107.46%
5.49%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States of America
MELVILLE